Appointment
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Prime Therapeutics
PR-10-24-NI-40Oct 11, 2024
Contract
Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance®
Prime Therapeutics
PR-M02-18-NI-013Feb 05, 2018